India is increasingly attracting off-shore investments, expanding its existing ventures into vaccines.With rediscovery of new variants of resistant disease-causing microbes, innovation and new launches are expected. The current market is estimated to be around 600 Cr. (Source: MAT Dec 09)

Sales from a panel of about 2500 stockists to various channels like retailers, hospitals (pharmacies located within the premises of the hospitals) and nursing Homes, dispensing doctors and NGO/ Institutions etc is tracked to increase the robustness of the data.

                                                                                                                                      For further information click here